We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

42 hedge funds and large institutions have $29.4M invested in InVivo Therapeutics Holdings Corp in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $32.9M → $29.4M (-$3.55M)

18% less funds holding

Funds holding: 51 → 42 (-9)

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

75% less call options, than puts

Call options by funds: $42K | Put options by funds: $170K

Holders
42
Holders Change
-9
Holders Change %
-17.65%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
4
Reduced
8
Closed
7
Calls
$42K
Puts
$170K
Net Calls
-$128K
Net Calls Change
+$246K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$8.4M
2
RJA
Raymond James & Associates
Florida
+$162K
3
RJFSA
Raymond James Financial Services Advisors
Florida
+$162K
4
State Street
State Street
Massachusetts
+$162K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$80.8K

Top Sellers

Rank Fund Capital Flow
1
WF
Welch & Forbes
Massachusetts
-$889K
2
Millennium Management
Millennium Management
New York
-$566K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$379K
4
GC
Guggenheim Capital
Illinois
-$242K
5
Citigroup
Citigroup
New York
-$162K
Name Holding Trade Value Shares
Change 		Change in
Stake
CDH
26
Charles D. Hyman
$121K – – –
Manulife (Manufacturers Life Insurance)
27
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$111K – – –
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$98K – – –
Wells Fargo
29
Wells Fargo
California
$94K – – –
LPL Financial
30
LPL Financial
California
$92K – – –
HighTower Advisors
31
HighTower Advisors
Illinois
$86K – – –
NFA
32
Nationwide Fund Advisors
Ohio
$81K – – –
AIG
33
American International Group
New York
$80K – – –
Cambridge Investment Research Advisors
34
Cambridge Investment Research Advisors
Iowa
$78K – – –
State Board of Administration of Florida Retirement System
35
State Board of Administration of Florida Retirement System
Florida
$78K – – –
FHA
36
Flagship Harbor Advisors
Massachusetts
$62K – – –
Bank of America
37
Bank of America
North Carolina
$61K – – –
VOYA Investment Management
38
VOYA Investment Management
Georgia
$59K – – –
ITIM
39
Indiana Trust & Investment Management
Indiana
$54K – – –
HKIM
40
Hayek Kallen Investment Management
Alabama
$49K – – –
Millennium Management
41
Millennium Management
New York
$48K -$566K -7 -88%
Legal & General Group
42
Legal & General Group
United Kingdom
$45K – – –
IA
43
IFP Advisors
Florida
$33K – – –
LTFS
44
Ladenburg Thalmann Financial Services
Florida
$33K – – –
Deutsche Bank
45
Deutsche Bank
Germany
$31K -$80.8K -1 Closed
AG
46
Advisor Group
Arizona
$31K – – –
Simplex Trading
47
Simplex Trading
Illinois
$23K – – –
Creative Planning
48
Creative Planning
Kansas
$17K -$80.8K -1 Closed
Barclays
49
Barclays
United Kingdom
$14K – – –
CAG
50
Crestwood Advisors Group
Massachusetts
$13K – – –
1
2
3

NVIV Hedge Fund Activity: Q1 2017 in Review

42 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q1 2017, worth a combined $29.4M — down 11% from $32.9M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of NVIV and 2 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 4 added.

The largest buyer was BlackRock, opening a new position worth an estimated $8.4M. The largest seller was Welch & Forbes, cutting an estimated $889K.

  • 42 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q1 2017, down from 51 in Q4 2016.
  • Funds reported $29.4M of InVivo Therapeutics Holdings Corp stock for Q1 2017, down 11% quarter-over-quarter.
  • 2 funds opened new InVivo Therapeutics Holdings Corp positions in Q1 2017 and 7 closed out, a net change of -5 holders.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q1 2017 was BlackRock, an estimated $8.4M added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q1 2017 was Welch & Forbes, an estimated $889K sold.

Based on aggregated 13F filings for Q1 2017.